Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00108927 · ClinicalTrials.gov registry record

Improving Diabetes in Primary Care (IMPACT)

A clinical trial of Hypertension and Diabetes Mellitus, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
6,000
Enrollment target
1
Study location

NCT00108927: Completed study of Hypertension and Diabetes Mellitus, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

NCT00108927 is a study of Hypertension and Diabetes Mellitus that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 6,000 participants, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (72% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00108927, a study of Hypertension and Diabetes Mellitus, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
6,000 participants
Enrollment target
1
Study location

Study Summary

The goal of our research program is to successfully translate empirical knowledge regarding diabetes treatment and management into sustainable clinical practice. The study hypothesis is that implementation of a multicomponent intervention will result in meaningful improvement in clinical performance measures at the clinic that include average A1c (Hemoglobin A1c), average systolic blood pressure, and national clinical performance measures at a reasonable cost to the health system.

Interventions

  • BEHAVIORAL TRANSLATE

Study Locations (1)

Minnesota

  • Dept of Family Medicine and Community Health, University of Minnesota Medical School - Minneapolis

Trial Details

FieldValue
Enrollment Target 6,000 participants
Start Date 2003-12
Est. Completion 2005-12

What the finished NCT00108927 record still lists

NCT00108927 is an observational study that tracks outcomes without assigning an intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,495-participant average among 470 other Hypertension trials with a reported enrollment target (72% higher).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which TRANSLATE is the first listed.

NCT00108927 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT00108927 about?

NCT00108927 is a clinical study titled "Improving Diabetes in Primary Care (IMPACT)". The goal of our research program is to successfully translate empirical knowledge regarding diabetes treatment and management into sustainable clinical practice. The study hypothesis is that implementation of a multicomponent intervention will result in meaningful improvement in clinical performance...

What is the current status of trial NCT00108927?

This trial is currently completed. The enrollment target is 6,000 participants. The study started on 2003-12. Estimated completion is 2005-12.

What conditions does trial NCT00108927 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus, Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT00108927?

The interventions under investigation include: TRANSLATE (BEHAVIORAL).

Who is sponsoring clinical trial NCT00108927?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00108927 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00108927's enrollment target sits among peer trials

6,000 25th of 470 higher than 446 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00005095 · 6,000 participants

    Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

  • NCT00280202 · 6,000 participants

    Detection of Genetic Markers of Lung Cancer

  • NCT03127631 · 6,000 participants · NA

    A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

  • NCT03539705 · 6,000 participants

    Food Allergy Registry at a Single Site

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00108927, the US trial registry maintained by the National Library of Medicine. NCT00108927 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.